Qualis Innovations Insiders
| QLISDelisted Stock | USD 0.27 0.00 0.00% |
Qualis Innovations employs about 7 people. The company is managed by 4 executives with a total tenure of roughly 17 years, averaging almost 4.0 years of service per executive, having 1.75 employees per reported executive. Breaking down Qualis Innovations' management performance can provide insight into the firm performance.
| Robert MD Insider Chief Officer |
| John Ballard Insider S CFO |
Qualis |
Qualis Innovations Management Team Effectiveness
The company has return on total asset (ROA) of (0.6965) % which means that it has lost $0.6965 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4481) %, meaning that it created substantial loss on money invested by shareholders. Qualis Innovations' management efficiency ratios could be used to measure how well Qualis Innovations manages its routine affairs as well as how well it operates its assets and liabilities.Qualis Innovations holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 87.62 pct. of Qualis Innovations outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Some institutional investors establish a significant position in pink sheets such as Qualis Innovations in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Qualis Innovations, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Qualis Innovations Workforce Comparison
Qualis Innovations is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Devices industry is at this time estimated at about 693. Qualis Innovations claims roughly 7.0 in number of employees contributing just under 2% to all equities under Medical Devices industry.
Qualis Innovations Notable Stakeholders
A Qualis Innovations stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Qualis Innovations often face trade-offs trying to please all of them. Qualis Innovations' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Qualis Innovations' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Robert MD | Chief Officer | Profile | |
| John Ballard | S CFO | Profile | |
| MD Pergolizzi | Acting Chairman | Profile | |
| James Thurman | Sr Communications | Profile |
About Qualis Innovations Management Performance
The success or failure of an entity such as Qualis Innovations often depends on how effective the management is. Qualis Innovations management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Qualis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Qualis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Qualis Innovations, Inc. focuses on the development, production, and distribution of pain management and other central nervous system based solutions. Its lead product is SOLACE, a non-invasive medical device to use electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. Qualis Innovations operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Please note, the imprecision that can be found in Qualis Innovations' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Qualis Innovations. Check Qualis Innovations' Beneish M Score to see the likelihood of Qualis Innovations' management manipulating its earnings.
Qualis Innovations Workforce Analysis
Traditionally, organizations such as Qualis Innovations use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Qualis Innovations within its industry.Qualis Innovations Manpower Efficiency
Return on Qualis Innovations Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 247.4K | |
| Net Loss Per Executive | 433K |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Qualis Pink Sheet
If you are still planning to invest in Qualis Innovations check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qualis Innovations' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |